XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
105 hedge funds and large institutions have $364M invested in Intersect ENT, Inc in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
25% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 28
2% more funds holding
Funds holding: 103 → 105 (+2)
Holders
105
Holding in Top 10
2
Calls
$2.18M
Puts
$1.42M
Top Buyers
| 1 | +$28.2M | |
| 2 | +$11.4M | |
| 3 | +$11M | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$6.65M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.26M |
Top Sellers
| 1 | -$6.82M | |
| 2 | -$6.72M | |
| 3 | -$4.86M | |
| 4 |
Millennium Management
New York
|
-$4.35M |
| 5 |
RA
Royce & Associates
New York
|
-$3.2M |